<p>Solicited adverse events following booster vaccination or in case of clade 2 primary vaccination within 3 to 7-days after vaccination.</p
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
Adverse events following first and second immunization of COVID-19 among the participants.</p
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
Unsolicited AEs within 28 days after any vaccine injections, by system organ class and preferred ter...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks a...
Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks a...
<p>Comparison of solicited adverse events following the first and second doses of vaccine (n = 44) a...
<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
*<p>These local reactions started in the 0–7 day period post vaccination but were reported in the 8–...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
Adverse events following first and second immunization of COVID-19 among the participants.</p
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
Unsolicited AEs within 28 days after any vaccine injections, by system organ class and preferred ter...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks a...
Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks a...
<p>Comparison of solicited adverse events following the first and second doses of vaccine (n = 44) a...
<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
*<p>These local reactions started in the 0–7 day period post vaccination but were reported in the 8–...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...
BACKGROUND: Studies have suggested incremental short-term adverse events (AE) after repeated vaccina...